O	0	6	FOXO3a	FOXO3a	NN	B-NP
O	7	14	elicits	elicit	VBZ	B-VP
O	15	16	a	a	DT	B-NP
O	17	20	pro	pro	AFX	I-NP
O	20	21	-	-	HYPH	I-NP
O	21	30	apoptotic	apoptotic	JJ	I-NP
O	31	44	transcription	transcription	NN	I-NP
O	45	52	program	program	NN	I-NP
O	53	56	and	and	CC	O
B-Cell	57	65	cellular	cellular	JJ	B-NP
O	66	74	response	response	NN	I-NP
O	75	77	to	to	TO	B-PP
O	78	83	human	human	JJ	B-NP
B-Organ	84	88	lung	lung	NN	I-NP
O	89	99	carcinogen	carcinogen	NN	I-NP
O	100	108	nicotine	nicotine	NN	I-NP
O	108	109	-	-	HYPH	O
O	109	116	derived	derive	VBN	B-VP
O	117	134	nitrosaminoketone	nitrosaminoketone	NN	B-NP
O	135	136	(	(	(	O
O	136	139	NNK	NNK	NN	B-NP
O	139	140	)	)	)	O
O	140	141	.	.	.	O

O	143	147	Long	Long	JJ	B-NP
O	147	148	-	-	HYPH	I-NP
O	148	152	term	term	NN	I-NP
O	153	163	carcinogen	carcinogen	NN	I-NP
O	164	172	exposure	exposure	NN	I-NP
O	173	179	exerts	exert	VBZ	B-VP
O	180	190	continuous	continuous	JJ	B-NP
O	191	199	pressure	pressure	NN	I-NP
O	200	202	on	on	IN	B-PP
O	203	206	key	key	JJ	B-NP
O	207	217	mechanisms	mechanism	NNS	I-NP
O	218	222	that	that	WDT	B-NP
O	223	229	repair	repair	VB	B-VP
O	230	232	or	or	CC	I-VP
O	233	242	eliminate	eliminate	VB	I-VP
O	243	253	carcinogen	carcinogen	NN	B-NP
O	253	254	-	-	HYPH	B-NP
O	254	261	damaged	damage	VBN	I-NP
B-Cell	262	267	cells	cell	NNS	I-NP
O	268	274	giving	give	VBG	B-VP
O	275	279	rise	rise	NN	B-NP
O	280	282	to	to	TO	B-PP
O	283	292	selective	selective	JJ	B-NP
O	293	301	failures	failure	NNS	I-NP
O	302	306	that	that	WDT	B-NP
O	307	317	contribute	contribute	VBP	B-VP
O	318	320	to	to	TO	B-PP
B-Cancer	321	325	lung	lung	NN	B-NP
I-Cancer	326	332	cancer	cancer	NN	I-NP
O	332	333	.	.	.	O

O	334	340	FOXO3a	FOXO3a	NN	B-NP
O	341	343	is	be	VBZ	B-VP
O	344	345	a	a	DT	B-NP
O	346	359	transcription	transcription	NN	I-NP
O	360	366	factor	factor	NN	I-NP
O	367	371	that	that	WDT	B-NP
O	372	379	elicits	elicit	VBZ	B-VP
O	380	381	a	a	DT	B-NP
O	382	392	protective	protective	JJ	I-NP
O	393	401	response	response	NN	I-NP
O	402	404	to	to	TO	B-PP
O	405	412	diverse	diverse	JJ	B-NP
B-Cell	413	421	cellular	cellular	JJ	I-NP
O	422	430	stresses	stress	NNS	I-NP
O	430	431	.	.	.	O

O	432	440	Although	Although	IN	B-SBAR
O	441	451	implicated	implicate	VBN	B-VP
O	452	454	as	as	IN	B-PP
O	455	456	a	a	DT	B-NP
B-Cancer	457	462	tumor	tumor	NN	I-NP
O	463	473	suppressor	suppressor	NN	I-NP
O	473	474	,	,	,	O
O	475	478	its	its	PRP$	B-NP
O	479	483	role	role	NN	I-NP
O	484	486	in	in	IN	B-PP
B-Cancer	487	495	sporadic	sporadic	JJ	B-NP
I-Cancer	496	502	cancer	cancer	NN	I-NP
O	503	505	is	be	VBZ	B-VP
O	506	515	uncertain	uncertain	JJ	B-ADJP
O	515	516	.	.	.	O

O	517	519	We	We	PRP	B-NP
O	520	528	recently	recently	RB	B-ADVP
O	529	537	observed	observe	VBD	B-VP
O	538	542	that	that	IN	B-SBAR
O	543	549	FOXO3a	FOXO3a	NN	B-NP
O	550	554	gene	gene	NN	I-NP
O	555	567	inactivation	inactivation	NN	I-NP
O	568	574	occurs	occur	VBZ	B-VP
O	575	585	frequently	frequently	RB	B-ADVP
O	586	588	in	in	IN	B-PP
O	589	599	carcinogen	carcinogen	NN	B-NP
O	599	600	-	-	HYPH	B-NP
O	600	607	induced	induce	VBN	I-NP
B-Cancer	608	612	lung	lung	NN	I-NP
I-Cancer	613	627	adenocarcinoma	adenocarcinoma	NN	I-NP
O	628	629	(	(	(	O
B-Cancer	629	632	LAC	LAC	NN	B-NP
O	632	633	)	)	)	O
O	633	634	.	.	.	O

O	635	639	This	This	DT	B-NP
O	640	648	suggests	suggest	VBZ	B-VP
O	649	653	that	that	IN	B-SBAR
O	654	660	FOXO3a	FOXO3a	NN	B-NP
O	661	664	may	may	MD	B-VP
O	665	669	play	play	VB	I-VP
O	670	671	a	a	DT	B-NP
O	672	676	role	role	NN	I-NP
O	677	679	in	in	IN	B-PP
B-Cancer	680	683	LAC	LAC	NN	B-NP
O	684	695	suppression	suppression	NN	I-NP
O	696	698	by	by	IN	B-PP
O	699	708	eliciting	elicit	VBG	B-VP
O	709	710	a	a	DT	B-NP
O	711	721	protective	protective	JJ	I-NP
O	722	730	response	response	NN	I-NP
O	731	733	to	to	TO	B-PP
O	734	746	carcinogenic	carcinogenic	JJ	B-NP
O	747	753	stress	stress	NN	I-NP
O	753	754	.	.	.	O

O	755	759	Here	Here	RB	B-ADVP
O	760	762	we	we	PRP	B-NP
O	763	775	investigated	investigate	VBD	B-VP
O	776	780	this	this	DT	B-NP
O	781	792	possibility	possibility	NN	I-NP
O	793	795	by	by	IN	B-PP
O	796	805	examining	examine	VBG	B-VP
O	806	809	the	the	DT	B-NP
O	810	814	role	role	NN	I-NP
O	815	817	of	of	IN	B-PP
O	818	824	FOXO3a	FOXO3a	NN	B-NP
O	825	827	in	in	IN	B-PP
O	828	831	the	the	DT	B-NP
B-Cell	832	840	cellular	cellular	JJ	I-NP
O	841	849	response	response	NN	I-NP
O	850	852	to	to	TO	B-PP
O	853	861	nicotine	nicotine	NN	B-NP
O	861	862	-	-	HYPH	O
O	862	869	derived	derive	VBN	B-VP
O	870	887	nitrosaminoketone	nitrosaminoketone	NN	B-NP
O	888	889	(	(	(	O
O	889	892	NNK	NNK	NN	B-NP
O	892	893	)	)	)	O
O	893	894	,	,	,	O
O	895	896	a	a	DT	B-NP
B-Organ	897	901	lung	lung	NN	I-NP
O	902	912	carcinogen	carcinogen	NN	I-NP
O	913	923	implicated	implicate	VBN	B-VP
O	924	926	as	as	IN	B-PP
O	927	928	a	a	DT	B-NP
O	929	934	cause	cause	NN	I-NP
O	935	937	of	of	IN	B-PP
O	938	943	human	human	JJ	B-NP
B-Cancer	944	947	LAC	LAC	NN	I-NP
O	947	948	.	.	.	O

O	949	951	We	We	PRP	B-NP
O	952	956	show	show	VBP	B-VP
O	957	961	that	that	IN	B-SBAR
O	962	973	restoration	restoration	NN	B-NP
O	974	976	of	of	IN	B-PP
O	977	983	FOXO3a	FOXO3a	NN	B-NP
O	984	986	in	in	IN	B-PP
O	987	993	FOXO3a	FOXO3a	NN	B-NP
O	993	994	-	-	HYPH	B-NP
O	994	1003	deficient	deficient	JJ	I-NP
B-Cell	1004	1007	LAC	LAC	NN	I-NP
I-Cell	1008	1013	cells	cell	NNS	I-NP
O	1014	1023	increases	increase	VBZ	B-VP
O	1024	1035	sensitivity	sensitivity	NN	B-NP
O	1036	1038	to	to	TO	B-PP
O	1039	1048	apoptosis	apoptosis	NN	B-NP
O	1049	1055	caused	cause	VBN	B-VP
O	1056	1058	by	by	IN	B-PP
O	1059	1060	a	a	DT	B-NP
O	1061	1064	DNA	DNA	NN	I-NP
O	1064	1065	-	-	HYPH	O
O	1065	1073	damaging	damage	VBG	B-VP
O	1074	1086	intermediate	intermediate	NN	B-NP
O	1087	1089	of	of	IN	B-PP
O	1090	1093	NNK	NNK	NN	B-NP
O	1093	1094	.	.	.	O

O	1095	1100	Prior	Prior	RB	B-ADVP
O	1101	1103	to	to	TO	B-PP
O	1104	1108	this	this	DT	B-NP
B-Cell	1109	1117	cellular	cellular	JJ	I-NP
O	1118	1125	outcome	outcome	NN	I-NP
O	1125	1126	,	,	,	O
O	1127	1133	FOXO3a	FOXO3a	NN	B-NP
O	1134	1136	is	be	VBZ	B-VP
O	1137	1149	functionally	functionally	RB	I-VP
O	1150	1159	activated	activate	VBN	I-VP
O	1160	1163	and	and	CC	O
O	1164	1172	mediates	mediate	VBZ	B-VP
O	1173	1174	a	a	DT	B-NP
O	1175	1180	large	large	JJ	I-NP
O	1180	1181	-	-	HYPH	I-NP
O	1181	1186	scale	scale	NN	I-NP
O	1187	1200	transcription	transcription	NN	I-NP
O	1201	1208	program	program	NN	I-NP
O	1209	1211	in	in	IN	B-PP
O	1212	1220	response	response	NN	B-NP
O	1221	1223	to	to	TO	B-PP
O	1224	1228	this	this	DT	B-NP
O	1229	1235	damage	damage	NN	I-NP
O	1236	1245	involving	involve	VBG	B-VP
O	1246	1247	a	a	DT	B-NP
O	1248	1259	significant	significant	JJ	I-NP
O	1260	1270	modulation	modulation	NN	I-NP
O	1271	1273	of	of	IN	B-PP
O	1274	1277	440	440	CD	B-NP
O	1278	1283	genes	gene	NNS	I-NP
O	1283	1284	.	.	.	O

O	1285	1290	Genes	Gene	NNS	B-NP
O	1291	1295	most	most	RBS	B-VP
O	1296	1309	significantly	significantly	RB	I-VP
O	1310	1321	represented	represent	VBN	I-VP
O	1322	1324	in	in	IN	B-PP
O	1325	1329	this	this	DT	B-NP
O	1330	1337	program	program	NN	I-NP
O	1338	1341	are	be	VBP	B-VP
O	1342	1347	those	those	DT	B-NP
O	1348	1352	with	with	IN	B-PP
O	1353	1358	roles	role	NNS	B-NP
O	1359	1361	in	in	IN	B-PP
B-Cell	1362	1366	cell	cell	NN	B-NP
O	1367	1373	growth	growth	NN	I-NP
O	1374	1377	and	and	CC	O
O	1378	1391	proliferation	proliferation	NN	B-NP
O	1391	1392	>	>	JJ	I-NP
O	1392	1399	protein	protein	NN	I-NP
O	1400	1409	synthesis	synthesis	NN	I-NP
O	1409	1410	>	>	SYM	B-NP
O	1410	1414	gene	gene	NN	I-NP
O	1415	1425	expression	expression	NN	I-NP
O	1425	1426	>	>	SYM	B-NP
B-Cell	1426	1430	cell	cell	NN	I-NP
O	1431	1436	death	death	NN	I-NP
O	1436	1437	>	>	SYM	B-NP
B-Cell	1437	1441	cell	cell	NN	I-NP
O	1442	1447	cycle	cycle	NN	I-NP
O	1447	1448	.	.	.	O

O	1449	1452	The	The	DT	B-NP
O	1453	1460	results	result	NNS	I-NP
O	1461	1463	of	of	IN	B-PP
O	1464	1468	this	this	DT	B-NP
O	1469	1474	study	study	NN	I-NP
O	1475	1479	show	show	VBP	B-VP
O	1480	1484	that	that	IN	B-SBAR
O	1485	1491	FOXO3a	FOXO3a	NN	B-NP
O	1492	1499	directs	direct	VBZ	B-VP
O	1500	1502	an	an	DT	B-NP
O	1503	1507	anti	anti	AFX	I-NP
O	1507	1508	-	-	HYPH	I-NP
O	1508	1520	carcinogenic	carcinogenic	JJ	I-NP
O	1521	1534	transcription	transcription	NN	I-NP
O	1535	1542	program	program	NN	I-NP
O	1543	1547	that	that	WDT	B-NP
O	1548	1558	culminates	culminate	VBZ	B-VP
O	1559	1561	in	in	IN	B-PP
O	1562	1565	the	the	DT	B-NP
O	1566	1577	elimination	elimination	NN	I-NP
O	1578	1580	of	of	IN	B-PP
O	1581	1591	carcinogen	carcinogen	NN	B-NP
O	1591	1592	-	-	HYPH	B-NP
O	1592	1599	damaged	damage	VBN	I-NP
B-Cell	1600	1605	cells	cell	NNS	I-NP
O	1605	1606	.	.	.	O

O	1607	1611	This	This	DT	B-NP
O	1612	1620	suggests	suggest	VBZ	B-VP
O	1621	1625	that	that	IN	B-SBAR
O	1626	1632	FOXO3a	FOXO3a	NN	B-NP
O	1633	1635	is	be	VBZ	B-VP
O	1636	1637	a	a	DT	B-NP
O	1638	1647	potential	potential	JJ	I-NP
O	1648	1658	suppressor	suppressor	NN	I-NP
O	1659	1661	of	of	IN	B-PP
O	1662	1674	carcinogenic	carcinogenic	JJ	B-NP
O	1675	1681	damage	damage	NN	I-NP
O	1682	1684	in	in	IN	B-PP
B-Cancer	1685	1688	LAC	LAC	NN	B-NP
O	1688	1689	.	.	.	O

